CINECA IRIS Institutional Research Information System

BERTINI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.607
EU - Europa 3.087
AS - Asia 1.072
AF - Africa 83
SA - Sud America 12
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.871
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.426
IT - Italia 1.214
CN - Cina 496
DE - Germania 459
SE - Svezia 455
BG - Bulgaria 323
TR - Turchia 179
CA - Canada 177
GB - Regno Unito 155
VN - Vietnam 143
FI - Finlandia 105
FR - Francia 92
AT - Austria 83
SG - Singapore 81
IN - India 75
UA - Ucraina 75
NG - Nigeria 61
HK - Hong Kong 54
RU - Federazione Russa 35
BE - Belgio 23
CH - Svizzera 20
JP - Giappone 20
CI - Costa d'Avorio 17
GR - Grecia 12
IL - Israele 8
AU - Australia 7
BR - Brasile 7
RO - Romania 7
RS - Serbia 7
NL - Olanda 5
ES - Italia 4
IR - Iran 4
SN - Senegal 4
DM - Dominica 3
ID - Indonesia 3
UY - Uruguay 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
EU - Europa 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AR - Argentina 1
AZ - Azerbaigian 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
IE - Irlanda 1
KR - Corea 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 10.871
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.037
Ann Arbor 766
Fairfield 656
Chandler 648
Houston 557
Serra 459
Ashburn 355
Sofia 323
Cambridge 271
Wilmington 256
Seattle 229
Beijing 195
New York 176
Ottawa 169
Izmir 167
Princeton 145
Lawrence 122
Medford 107
Milan 107
Nanjing 97
Jacksonville 86
Vienna 76
Dong Ket 74
Pisa 71
Marseille 64
Lagos 61
Des Moines 59
Nanchang 54
Dearborn 53
Hong Kong 52
London 49
Florence 47
Redwood City 46
Boulder 36
San Diego 35
Pune 24
Los Angeles 23
Rome 23
Nürnberg 22
Pistoia 22
Brussels 21
Shenyang 21
Kunming 19
Norwalk 18
Abidjan 17
Bern 16
Jiaxing 13
Ogden 13
Jüchen 12
Hebei 11
Livorno 11
Tianjin 11
Carrara 10
Falls Church 10
Hangzhou 10
Hefei 10
Mumbai 10
Orange 10
San Francisco 10
Zola Predosa 10
Washington 9
Boardman 8
Changsha 8
Guangzhou 8
Jinan 8
Phoenix 8
Lucca 7
Auburn Hills 6
Favria 6
Frankfurt am Main 6
Leawood 6
Albenga 5
Bat Yam 5
Bremen 5
Dallas 5
Delhi 5
Indiana 5
New Delhi 5
Piombino 5
Rende 5
Tokyo 5
Berlin 4
Bochum 4
Dakar 4
Fuzhou 4
Genova 4
Hyderabad 4
Istanbul 4
Makuharihongo 4
Mountain View 4
Perugia 4
Wuhan 4
Bientina 3
Cerveteri 3
Chengdu 3
Chicago 3
Costa Mesa 3
Helsinki 3
Huércal De Almería 3
Jakarta 3
Totale 8.280
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 255
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 158
Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors 157
Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor 153
Application of An Improved HPLC-FL Method to Screen Serine Palmitoyl Transferase Inhibitors 152
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 151
Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes 147
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system 147
Identification of the first synthetic allosteric modulator of the CB2receptors and evidence of its efficacy for neuropathic pain relief 147
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 142
Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model 142
Anti-proliferative activity of oleocanthal in human malignant cutaneous melanoma cells 141
4-[6-(dansylamino)hexylamino]-7-methyl-2-phenyl-1,8-naphthyridine as a new potential fluorescent probe for studying A1-adenosine receptor 141
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 137
Efficient application of monolithic silica column to determination of illicit heroin street sample by HPLC 137
Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors 136
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 136
Rational design, synthesis, biological evaluation and labelling of selective cannabinoid CB2 receptor agonists as anticancer agents 132
7-Nitrobenzofurazan (NBD)-Derivatives Of 5'-N-Ethylcarboxamidoadenosine (NECA) As New Fluorescent Probes For Human A3 Adenosine Receptors 132
Estrogen receptor ligands: a patent review update 132
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor 131
Development of an HPLC/UV assay for the evaluation of inhibitors of human recombinant monoacylglycerol lipase 130
Selective activators of estrogen receptor beta based on the aldoxime and ketoxime scaffolds 128
CB2-Selective Cannabinoid Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides 127
Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands 126
Antiproliferative oxime derivatives that inhibit glucose transporter 1 (GLUT1) in cancer cells 124
Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials 124
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition 122
Composition of health-promoting phenolic compounds in two extra-virgin olive oils and diversity of associated yeasts 122
Metabolically labile cannabinoid esters: A ‘soft drug’ approach for the development of cannabinoid-based therapeutic drugs 120
Ceramide analogues in apoptosis: a new strategy for anticancer drug development 120
Diaryl-substituted salicyl- and anthranyl-ketoximes as potential estrogen receptor ligands 115
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells 115
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 114
Synthesis of a Resveratrol Analogue with High Ceramide-Mediated Proapoptotic Activity on Human Breast Cancer Cells 113
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 113
Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors 113
Development of Methods for Recovering Endotoxins from Surfaces and from Air in Production Environment of Injectable Drugs 109
Synthesis and antiviral properties of novel analogues of monophosphate and diphosphate bioactive forms of acyclovir 108
BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides 107
Antiproliferative activity and cell cycle analysis of 2-(3,5-dihydroxyphenyl)-6-hydroxybenzothiazole on MCF-7 breast and HCT-15 colon cancer cell lines. 107
Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues 105
Variously substituted (phosphonoacetamido)oxy analogues of geranylgeranyl diphosphate (GGdP) as GGdP-transferase (GGTase) inhibitors and antiproliferative agents 105
Synthesis of aniline-type analogues of farnesyl diphosphate and their biological assays for prenyl protein transferase inhibitory activity 105
Synthesis, Antifungal Activity, and Molecular Modeling Studies of New Inverted Oxime Ethers of Oxiconazole 103
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 103
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: Implications for drug discovery 103
Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands 103
Aminobenzothiazoles as beta-Selective Estrogen Receptor Ligands 102
Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells 102
Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity 101
Carbazole-containing arylcarboxamides as BACE1 inhibitors 100
alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors 99
null 98
A theoretical study to investigate D2DAR/D4DAR selectivity: Receptor modeling and molecular docking of dopaminergic ligands 97
Biphenyl-Derivatives Possessing Tertiary Amino Groups as ß-Secretase (BACE1) Inhibitors 97
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes 97
Novel Estrogen Receptor Ligands Based on an Anthranylaldoxime Structure: Role of the Phenol-Type Pseudocycle in the Binding Process 95
200 Esercizi Risolti di Chimica Generale ed Inorganica 94
18FLUORINE-LABELED NITROGEN HETEROCYCLIC DERIVATIVES AS NEW CANDIDATE FOR CANNABINOID CB2 RECEPTOR PET IMAGING 92
Aromatic aldoximes as Estrogen Receptor Beta–Selective Ligands 92
Aminobenzothiazoles as inhibitors of tau-fibril formation in Alzheimer's and other neurodegenerative diseases 92
SERINE PALMITOYLTRANSFERASE INHIBITION: A VIRTUAL SCREENING HYPOTHESIS 88
Stable propylphosphonic acid analogues of geranylgeranyl diphosphate possessing inhibitory activity on geranylgeranyl protein transferase 88
Multi-targeted ChEI-copper chelating molecules as neuroprotective agents 84
Salicylaldoxime moiety as a phenolic “A-ring” substitute in estrogen receptor ligands 83
Synthetic hydroxylated aryl-naphthalene derivatives as resveratrol rigid analogues showing ceramide-mediated antiproliferative and pro-apoptotic properties 82
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis 81
Stable analogues of geranylgeranyl diphosphate endowed of improved geranylgeranyl vs. farnesyl protein transferase inhibitory selectivity 80
Attività antiproliferativa dell’oleocantale in cellule umane di melanoma cutaneo maligno. 80
Salicylaldoxime Moiety as a Phenolic "A-Ring" Substitute in Estrogen Receptor Ligands 77
N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation 77
Predictions of binding of estrogen receptor agonists by a combination of molecular dynamics and continuum solvent models 76
N-Metilantranilaldossime aril-sostituite come ligandi estrogenici 75
Stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side-chain as inhibitors of prenyl protein transferases 74
Alternatives to phenol-based estrogen receptor ligands 73
Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-Substituted 3,4-Diarylsalicylaldoximes on estrogen receptors a and ß 71
Structural Evolutions of Salicylaldoximes as Selective Agonists for Estrogen Receptor Beta 71
Purification, Enzymatic Characterization and Inhibition of the Z-Farnesyl Diphosphate Synthase from Mycobacterium tuberculosis 68
Alzheimer Diseases: Design and synthesis of new BACE inhibitors 67
Radiosensitizing potential of small organic molecules toward hypoxic tumor cells in the radiotherapy 67
Purification, Enzymatic Characterization, and Inhibition of the Z-Farnesyl Diphosphate Synthase from Mycobacterium tuberculosis 65
Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist 65
Synthesis and Biology of NBD-Derivatives of Neca as New Fluorescent Probes for Adenosine Receptors 64
Synthesis of 18F-labeled nitrogen heterocyclic derivatives as new candidate for cannabinoid CB2 receptor PET imaging 63
Monoaryl-substituted Salicylaldoximes as Ligands for Estrogen Receptor Beta 63
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis 63
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators 62
Salicylaldoxime-Based Ligands for Estrogen Receptor Beta Showing Potent Agonist Properties 60
CARDIOVASCULAR ACTIVITY OF BETA ESTROGEN RECEPTOR SELECTIVE SYNTHETIC LIGANDS 60
Assessment of a HPLC assay for monoacylglycerol lipase activity 58
Halogen-selective cross-coupling reactions in the synthesis of ligands for the estrogen receptors 57
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases 57
Design, synthesis and biological evaluation of 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as soft-drugs 56
Salicil- ed antranil-aldossime ad azione estrogenica: ruolo dell’anello pseudo-fenolico 56
Nuovi agonisti non steroidei per il recettore beta degli estrogeni 55
NEW NON STEROIDAL AGONISTS OF ESTROGEN RECEPTOR β 55
Effetto dell'introduzione di porzioni lipofile o idrofile sull'attività antiproliferativa di analoghi semirigidi delle ceramidi intracellulari 53
Cannabinoid-Based Medicines and Multiple Sclerosis 53
Synthesis and biological evaluation of pyridine derivatives as cannabinoid receptor ligands 52
Totale 10.127
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.072
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019477 0 0 0 0 0 0 0 0 0 0 280 197
2019/20201.988 246 131 253 120 151 214 220 141 151 112 202 47
2020/20211.010 67 51 34 69 100 56 79 122 113 92 59 168
2021/20221.478 30 184 53 52 225 185 61 76 31 51 77 453
2022/20231.835 210 276 145 158 246 241 11 134 267 12 85 50
2023/2024888 105 108 109 43 154 204 86 37 17 19 6 0
Totale 11.167